Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

ORIC Oric Pharmaceuticals Inc

7,64

-0,39 (-4,86%)

04 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Oric Pharmaceuticals Charts.

Oric Pharmaceuticals (NASDAQ:ORIC)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Oric Pharmaceuticals Charts.

News Oric Pharmaceuticals Inc

Form 8-K - Current report
Dienstag 25 Februar 2025 (6 Tage vor) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Announces Focused Registrational Clinical Development Plans for Lead Programs, Extended Cash Runway, and Updated Corporate Milestones
Dienstag 25 Februar 2025 (6 Tage vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dienstag 18 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 18 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Updates
Dienstag 18 Februar 2025 (2 Wochen vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 7 Februar 2025 (3 Wochen vor) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Montag 27 Januar 2025 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 13 Januar 2025 (2 Monate vor) • Edgar (US Regulatory)

ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
Montag 13 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Announces Clinical Supply Agreement to Evaluate ORIC-114 in Combination with Amivantamab for the First-Line Treatment of NSCLC with EGFR Exon 20 Insertion Mutations
Montag 13 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

ORIC® Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Freitag 3 Januar 2025 (2 Monate vor) • GlobeNewswire Inc.

Weitere Oric Pharmaceuticals Inc News-Artikel

Syndax Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen